The cost of treatment with redecision COVID-19 will be 2340 dollars

Gilead announced the pricing of ramdevpir: in the US the treatment of one patient with coronavirus new drug will cost 2340 dollars. One vial of the drug in the United States and for governments in developing countries will cost $ 390, while American insurance companies have to pay 520 dollars for a bottle (and 3120 dollars for a five-day course), writes Reuters.

Antiretroviral ramdevpir was the first drug that demonstrated in clinical studies its effectiveness in the treatment of coronavirus infection. Gilead has already signed an agreement with the U.S. government on the use of ramdevpir therapy COVID-19, the agreement will be valid until the end of September 2020.

Currently, medicine is available in form for intravenous injection, however, in August 2020 Gilead intends to begin clinical trials more easy to use form LS – inhalation.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]